These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28495396)

  • 21. Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
    Drosos GC; Konstantonis G; Sfikakis PP; Tektonidou MG
    Eur J Prev Cardiol; 2021 Apr; 28(3):346-352. PubMed ID: 33891687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Obesity related risk for chronic kidney disease progression and cardiovascular disease after propensity score matching.
    Barbieri D; Goicoechea M; García-Prieto A; Delgado A; Verde E; Verdalles U; Pérez de José A; Carbayo J; Muñoz de Morales A; Luño J
    Hipertens Riesgo Vasc; 2021; 38(2):63-71. PubMed ID: 33759767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Eyileten T; Gezer M; Verim S; Oguz Y; Vural A; Ortiz A; Johnson RJ; Covic A; Yilmaz MI
    Int Urol Nephrol; 2016 Jul; 48(7):1129-36. PubMed ID: 27007614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Framingham function overestimates the risk of ischemic heart disease in HIV-infected patients from Barcelona.
    Herrera S; Guelar A; Sorlì L; Vila J; Molas E; Grau M; Marrugat J; Esteve E; Güerri-Fernández R; Montero M; Knobel H
    HIV Clin Trials; 2016 Jul; 17(4):131-9. PubMed ID: 27169692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program.
    Greffin S; André MB; Matos JPS; Kang HC; Jorge AJL; Rosa MLG; Lugon JR
    J Bras Nefrol; 2017; 39(3):246-252. PubMed ID: 28902230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Framingham risk score with cardiovascular events in chronic kidney disease.
    Chen SC; Su HM; Tsai YC; Huang JC; Chang JM; Hwang SJ; Chen HC
    PLoS One; 2013; 8(3):e60008. PubMed ID: 23527293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Shah R; Matthews GJ; Shah RY; McLaughlin C; Chen J; Wolman M; Master SR; Chai B; Xie D; Rader DJ; Raj DS; Mehta NN; Budoff M; Fischer MJ; Go AS; Townsend RR; He J; Kusek JW; Feldman HI; Foulkes AS; Reilly MP;
    Am J Kidney Dis; 2015 Aug; 66(2):266-73. PubMed ID: 25795074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
    Alderson HV; Ritchie JP; Middleton R; Larsson A; Larsson TE; Kalra PA
    Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study.
    Bundy JD; Rahman M; Matsushita K; Jaeger BC; Cohen JB; Chen J; Deo R; Dobre MA; Feldman HI; Flack J; Kallem RR; Lash JP; Seliger S; Shafi T; Weiner SJ; Wolf M; Yang W; Allen NB; Bansal N; He J;
    J Am Soc Nephrol; 2022 Mar; 33(3):601-611. PubMed ID: 35145041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Soluble TWEAK and Major Adverse Cardiovascular Events in Patients with CKD.
    Fernández-Laso V; Sastre C; Valdivielso JM; Betriu A; Fernández E; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Clin J Am Soc Nephrol; 2016 Mar; 11(3):413-22. PubMed ID: 26728587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socio-economic disparities in the distribution of cardiovascular risk in chronic kidney disease stage 3.
    Fraser SD; Roderick PJ; McIntyre NJ; Harris S; McIntyre CW; Fluck RJ; Taal MW
    Nephron Clin Pract; 2012; 122(1-2):58-65. PubMed ID: 23548499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y; Yilmaz MI; Siriopol D; Saglam M; Unal HU; Yaman H; Gok M; Cetinkaya H; Gaipov A; Eyileten T; Sari S; Yildirim AO; Tonbul HZ; Turk S; Covic A; Kanbay M
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
    Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular events and death in Japanese patients with chronic kidney disease.
    Tanaka K; Watanabe T; Takeuchi A; Ohashi Y; Nitta K; Akizawa T; Matsuo S; Imai E; Makino H; Hishida A;
    Kidney Int; 2017 Jan; 91(1):227-234. PubMed ID: 27884399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between platelet indices and cardiovascular events in chronic kidney disease patients without dialysis.
    Yu Z; Xiong J; Yang K; Huang Y; He T; Yu Y; Zhao J
    Int Urol Nephrol; 2021 May; 53(5):961-971. PubMed ID: 33387224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential impact of peripheral endothelial dysfunction on subsequent cardiovascular events following percutaneous coronary intervention between chronic kidney disease (CKD) and non-CKD patients.
    Tabata N; Hokimoto S; Akasaka T; Arima Y; Sakamoto K; Yamamoto E; Tsujita K; Izumiya Y; Yamamuro M; Kojima S; Kaikita K; Ogawa H
    Heart Vessels; 2016 Jul; 31(7):1038-44. PubMed ID: 26164597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study.
    Sciarretta S; Valenti V; Tocci G; Pontremoli R; Rosei EA; Ambrosioni E; Costa V; Leonetti G; Pessina AC; Trimarco B; Chin D; Paneni F; Deferrari G; Ferrucci A; Volpe M
    J Hypertens; 2010 Feb; 28(2):251-8. PubMed ID: 19812502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Poudel B; Rosenson RS; Kent ST; Bittner V; Gutiérrez OM; Anderson AH; Woodward M; Jackson EA; Monda KL; Bajaj A; Huang L; Kansal M; Rahman M; He J; Muntner P; Colantonio LD;
    Kidney Med; 2023 Jul; 5(7):100648. PubMed ID: 37492110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores.
    Kawai VK; Chung CP; Solus JF; Oeser A; Raggi P; Stein CM
    Arthritis Rheumatol; 2015 Feb; 67(2):381-5. PubMed ID: 25371313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A 10- and 15-year performance analysis of ESC/EAS and ACC/AHA cardiovascular risk scores in a Southern European cohort.
    Santos-Ferreira C; Baptista R; Oliveira-Santos M; Moura JP; Gonçalves L
    BMC Cardiovasc Disord; 2020 Jun; 20(1):301. PubMed ID: 32560700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.